|
1
|
Faderl S, O'Brien S, Pui CH, Stock W,
Wetzler M, Hoelzer D and Kantarjian HM: Adult acute lymphoblastic
leukemia: Concepts and strategies. Cancer. 116:1165–1176. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fielding AK, Richards SM, Chopra R,
Lazarus HM, Litzow MR, Buck G, Durrant IJ, Luger SM, Marks DI,
Franklin IM, et al Medical Research Council: of the United Kingdom
Adult ALL Working Party; Eastern Cooperative Oncology Group:
Outcome of 609 adults after relapse of acute lymphoblastic leukemia
(ALL); an MRC UKALL12/ECOG 2993 study. Blood. 109:944–950. 2007.
View Article : Google Scholar
|
|
3
|
Shishido S, Bönig H and Kim YM: Role of
integrin alpha4 in drug resistance of leukemia. Front Oncol.
4:992014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clark BR and Keating A: Biology of bone
marrow stroma. Ann N Y Acad Sci. 770:70–78. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Juarez J, Baraz R, Gaundar S, Bradstock K
and Bendall L: Interaction of interleukin-7 and interleukin-3 with
the CXCL12-induced proliferation of B-cell progenitor acute
lymphoblastic leukemia. Haematologica. 92:450–459. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gaundar SS, Bradstock KF and Bendall LJ:
p38MAPK inhibitors attenuate cytokine production by bone marrow
stromal cells and reduce stroma-mediated proliferation of acute
lymphoblastic leukemia cells. Cell Cycle. 8:2975–2983. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Malfuson JV, Boutin L, Clay D, Thépenier
C, Desterke C, Torossian F, Guerton B, Anginot A, de Revel T,
Lataillade JJ and Le Bousse-Kerdilès MC: SP/drug efflux
functionality of hematopoietic progenitors is controlled by
mesenchymal niche through VLA-4/CD44 axis. Leukemia. 28:853–864.
2014. View Article : Google Scholar
|
|
8
|
van Dongen JJ, van der Velden VH,
Brüggemann M and Orfao A: Minimal residual disease diagnostics in
acute lymphoblastic leukemia: Need for sensitive, fast, and
standardized technologies. Blood. 125:3996–4009. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Casey SC, Vaccari M, Al-Mulla F,
Al-Temaimi R, Amedei A, Barcellos-Hoff MH, Brown DG, Chapellier M,
Christopher J, Curran CS, et al: The effect of environmental
chemicals on the tumor microenvironment. Carcinogenesis. 36(Suppl
1): S160–S183. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pereira FA, Qiu Y, Zhou G, Tsai MJ and
Tsai SY: The orphan nuclear receptor COUP-TFII is required for
angiogenesis and heart development. Genes Dev. 13:1037–1049. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xie X, Qin J, Lin SH, Tsai SY and Tsai MJ:
Nuclear receptor chicken ovalbumin upstream promoter-transcription
factor II (COUP-TFII) modulates mesenchymal cell commitment and
differentiation. Proc Natl Acad Sci USA. 108:14843–14848. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Safe S, Jin UH, Hedrick E, Reeder A and
Lee SO: Minireview: Role of orphan nuclear receptors in cancer and
potential as drug targets. Mol Endocrinol. 28:157–172. 2014.
View Article : Google Scholar :
|
|
13
|
Yang Y, Mallampati S, Sun B, Zhang J, Kim
SB, Lee JS, Gong Y, Cai Z and Sun X: Wnt pathway contributes to the
protection by bone marrow stromal cells of acute lymphoblastic
leukemia cells and is a potential therapeutic target. Cancer Lett.
333:9–17. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu K, Gu Y, Lou L, Liu L, Hu Y, Wang B,
Luo Y, Shi J, Yu X and Huang H: Galectin-3 mediates bone marrow
microenvironment-induced drug resistance in acute leukemia cells
via Wnt/β-catenin signaling pathway. J Hematol Oncol. 8:12015.
View Article : Google Scholar
|
|
15
|
Beresford MJ, Wilson GD and Makris A:
Measuring proliferation in breast cancer: Practicalities and
applications. Breast Cancer Res. 8:2162006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li L, Xie X, Qin J, Jeha GS, Saha PK, Yan
J, Haueter CM, Chan L, Tsai SY and Tsai MJ: The nuclear orphan
receptor COUP-TFII plays an essential role in adipogenesis, glucose
homeostasis, and energy metabolism. Cell Metab. 9:77–87. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang B, Hu Y, Liu L, Hu K, Tie R, He Y, Fu
S, Zhu N, Luo Y, Yu X and Huang H: Phenotypical and functional
characterization of bone marrow mesenchymal stem cells in patients
with chronic graft-versus-host disease. Biol Blood Marrow
Transplant. 21:1020–1028. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Hu K, Hu Y, Liu L, Wang B and
Huang H: Bone marrow mesenchymal stromal cells affect the cell
cycle arrest effect of genotoxic agents on acute lymphocytic
leukemia cells via p21 down-regulation. Ann Hematol. 93:1499–1508.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X, Qin J, Cheng CM, Tsai MJ and Tsai
SY: COUP-TFII is a major regulator of cell cycle and Notch
signaling pathways. Mol Endocrinol. 26:1268–1277. 2012. View Article : Google Scholar : PubMed/NCBI
|
